Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases

Bone Marrow Transplantation

Volumn 30, Issue 11, 2002, Pages 753-759

  Hinterberger, W ^a   Hinterberger Fischer, M ^a   Marmont, A ^b  

^a DANUBE HOSPITAL   (Austria)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Autoimmune disease; Graft versus autoimmunity; Hemopoeitic stem cell transplantation

Indexed keywords

ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; ANTITHYROID AGENT; BUSULFAN; CD34 ANTIGEN; CHLORAMPHENICOL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; FLUDARABINE; GOLD SALT; LYMPHOCYTE ANTIBODY; METHOTREXATE; PROCARBAZINE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOTRANSPLANTATION; BLOOD DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; ISOTRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEDLINE; PRIORITY JOURNAL; RECURRENCE RISK; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHILD; DATA COLLECTION; DISEASE-FREE SURVIVAL; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0036901840     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703686     Document Type: Article

References (59)

1. van Bekkum DW. BMT in experimental autommume disease. Bone Marrow Transplant 1993; 11: 183-187.
2. van Gelder M, Kinwel-Bohre EPM, van Bekkum DW. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 1993; 11: 233-241.
3. Wicker LS, Miller BJ, Chai A et al. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. J Exp Med 1988; 167: 1801-1810.
4. Marmont AM. Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases. J Rheumatol 1997; 24: (Suppl. 48) 13-18.
5. Ikehara S. Treatment of autoimmune diseases by hemopoietic stem cell transplantation. Exp Hematol 2001; 29: 661-669.
6. Jarvinen P, Aho K. Twin studies in rheumatic diseases. Semin Arthritis Rheum 1994; 24: 19-28.
7. Slavin S, Nagler A, Varadi G et al. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853-857.
8. Marmont AM. Lupus: tinkering with haemopoietic stem cells. Lupus 2001; 10: 769-774.
9. Marmont AM. Immunoablation followed or not by haemopoietic stem cells as an intense therapy for severe autoimmune diseases. New perspectives, new problems. Haematologica 2001; 86: 337-345.
10. Baldwin JL, Storb R, Thomas ED et al. Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977; 20: 1043-1048.
11. Jacobs P, Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant 1986; 1: 237-239.
12. Lowenthal RM, Cohen ML, Atkinson K et al. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 1993; 20: 137-140.
13. Snowden JA, Kearney P, Kearney A et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 1998; 41: 453-459.
14. McKendry RJR, Huebsch L, Leclair B. Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13 year follow-up. Arthritis Rheum 1996; 39: 1246-1253.
15. Masszi T, Remenyi P, Fekete S. Successful treatment of psoriasis by allogeneic bone marrow transplantation in a severe aplastic anemia patient. Bone Marrow Transplant 1997; 19 (Suppl. 1): 818.
16. Nelson JL, Torrez R, Louie FM et al. Pre-existing autoimmune disease in patients with longterm survival after allogeneic bone marrow transplantation. J Rheumatol 1997; 24 (Suppl. 48): 23-29.
17. Cetkovsky P, Koza V, Cetkovska P et al. Successful treatment of severe Shulman's syndrome by allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 21: 637-639.
18. Kim SW, Rice L, Champlin R et al. Aplastic anemia in eosinophilic fasciitis: responses to immunosuppression and marrow transplantation. Haematologia 1997; 28: 131-137.
19. Yokota A, Hukazawa M, Nakaseko C et al. Resolution of psoriasis vulgaris following allogeneic bone marrow transplantation for aplastic anemia. Rinsho Ketsueki 1996; 37: 35-39.
20. Diez S, Banias H, Diez-Martin JL et al. Apparent cure of Graves-Basedow disease after sibling allogeneic bone marrow transplantation. Clin Endocrinol 1999; 50: 267-270.
21. Gur-Lavi M. Long-term remission with allogeneic bone marrow transplantation in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1777-1778.
22. Lee WY, Oh ES, Min CK et al. Changes in autoimmune thyroid disease following allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28: 63-66.
23. Lopez-Cubero SO, Sullivan KM, McDonald GB. Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 1998; 114: 433-440.
24. Talbot DC, Montes A, Teh WL et al. Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemia. Hosp Med 1998; 59: 580-581.
25. Eedy DJ, Burrows D, Bridges JM et al. Clearance of severe psoriasis after allogenic bone marrow transplantation. Br Med J 1990; 300: 908.
26. Liu Yin JA, Jowitt SN. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1992; 9: 31-33.
27. Burt RK, Burns W, Hess A. Bone marrow transplantation for multiple sclerosis. Bone Marrow Transplant 1995; 16: 1-6.
28. Vento S, Cainelli F, Renzini C et al. Resolution of autoimmune hepatitis after bone marrow transplantation. Lancet 1996; 348: 544-545.
29. McAllister LD, Beatty PG, Rose J. Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis. Bone Marrow Transplant 1997; 19: 395-397.
30. Brinch L, Evensen SA, Tjonnfjord GE et al. Long term remission of Crohn's disease after AML treatment and allogeneic marrow transplantation. Bone Marrow Transplant 1997; 19 (Suppl. 1): 820.
31. Kishimoto Y, Yamamoto Y, Ito T et al. Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 1041-1043.
32. Adkins DR, Abidi MH, Brown RA et al. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy. Bone Marrow Transplant 2000; 26: 1239-1241.
33. Slavin S, Nagler A, Varadi G et al. Graft-vs-autoimmunity following non myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853-857.
34. Mandalfino P, Rice G, Smith A et al. Bone marrow transplantation in multiple sclerosis. J Neurol 2000; 247: 691-695.
35. Euler HH, Marmont AM, Bacigalupo A et al. Early recurrence or persistence of autoimmune disease after unmanipulated autologous stem cell transplantation. Blood 1996; 88: 3621-3625.
36. + stem cells. Blood 1994; 84 (Suppl. 1): 206a.
37. Cooley HM, Snowden JA, Grigg AG et al. Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy. Arthritis Rheum 1997; 40: 1712-1715.
38. Snowden JA, Patton WN, O'Donnell JL et al. Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 1997; 19: 1247-1250.
39. Schinco PC, Tamponi G, Montarulli B et al. Low antibody response in a hemophiliac with natural anti-VIII: C inhibitors treated with HDS and autograft for a concomitant non-Hodgkin's lymphoma. Bone Marrow Transplant 1998; 21 (Suppl. 1): A186.
40. Rosler W, Manger B, Repp R et al. Autologous PBPCT in a patient with lymphoma and Sjögren's syndrome: complete remission of lymphoma without control of the autoimmune disease. Bone Marrow Transplant 1998; 22: 211-213.
41. Schachna L, Ryan PF, Schwarer AP. Malignancy-associated remission of systemic lupus erythematosus maintained by autologous peripheral blood stem cell transplantation. Arthritis Rheum 1998; 41: 2271-2272.
42. Meloni G, Capria S, Vignetti M et al. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. Blood 1997; 89: 4659.
43. + cell transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications. Bone Marrow Transplant 1999; 24: 215-217.
44. Musso M, Porretto F, Crescimanno A et al. Crohn's disease complicated by relapsed extranodal Hodgkin's lymphoma: prolonged complete remission after unmanipulated PBPC autotransplant. Bone Marrow Transplant 2000; 26: 921-923.
45. Caspi O, Polliack A, Klar R et al. The association of inflammatory bowel disease and leukemia - coincidence or not? Leuk Lymphoma 1995; 17: 255-262.
46. Drakos PE, Nagler A, Or R. Case of Crohn's disease in bone marrow transplantation. Am J Hematol 1993; 43: 157-158.
47. Kashyap A, Forman SJ. Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's disease. Br J Haematol 1998; 103: 651-652.
48. Meloni G, Capria S, Salvetti M et al. Autologous peripheral blood stem cell transplantation in a patient with multiple sclerosis and concomitant Ph+ acute leukemia. Haematologica 1999; 84: 665-667.
49. Jondeau K, Job-Deslandre C, Bouscary D et al. Remission of nonerosive polyarthritis associated with Sjögren's syndrome after autologous hematopoietic stem cell transplantation for lymphoma. J Rheumatol 1997; 24: 2466-2468.
50. Jantunen E, Myllykangas-Luosujarvi R, Kaipiainen-Seppanen O et al. Autologous stem cell transplantation in a lymphoma patient with a long history of ankylosing spondylitis. Rheumatology (Oxford) 2000; 39: 563-564.
51. Ferraccioli G, Damato R, De Vita S et al. Haematopoietic stem cell transplantation in a patients with Sjögren's syndrome and lung malt lymphoma cured lymphoma not the autoimmune disease. Ann Rheum Dis 2001; 60: 174-176.
52. Euler HH. A preliminary definition of the term 'cure' as applied to systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1552.
53. Schranz DB, Lenmark A. Immunology in diabetes: an update. Diabetes Metab Rev 1998; 14: 3-29.
54. Li H, Kaufman CL, Boggs SS et al. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J Immunol 1996; 156: 380-387.
55. Seung E, Iwakosh N, Woda BA et al. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 2000; 95: 2175-2387.
56. McSweeny PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high dose cytotoxic therapy with graft versus tumor effects. Blood 2001; 97: 3390-3400.
57. McColl G, Kohsaka H, Szer J et al. High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid. Ann Intern Med 1999; 131: 507-509.
58. Hinterberger W, Rowlings PA, Hinterberger-Fischer M et al. Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med 1997; 126: 116-122.
59. Young NS. Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia. Semin Hematol 2000; 37: 3-14.